Clinical Trials Directory

Trials / Conditions / Neuroprotection

Neuroprotection

15 registered clinical trials studyying Neuroprotection — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingEvaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma
NCT07322965
Institut Catala de RetinaN/A
CompletedLocal Ischemic Postconditioning in Acute Ischemic Stroke
NCT06526429
Shanghai Jiao Tong University Affiliated Sixth People's HospitalN/A
CompletedEffect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram i
NCT06431113
Fondazione IRCCS Policlinico San Matteo di PaviaPhase 3
RecruitingEffectiveness and Biological Mechanism of Direct Ischemic Post-conditioning for Acute Stroke Patients Due to L
NCT06545734
Tianjin Huanhu HospitalPhase 2
UnknownMagnesium Sulphate Neuroprotective Strategies for Preterm Deliveries
NCT05674565
Zagazig UniversityPhase 2 / Phase 3
CompletedEffect of BrainPhyt, a Microalgae Based Ingredient on Cognitive Function in Healthy Older Subjects
NCT04832412
MicrophytN/A
UnknownNeuroprotective Effects of iTBS in PD
NCT05445505
Ruijin HospitalN/A
CompletedTreatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke
NCT05404373
Capital Medical UniversityN/A
CompletedNormobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke
NCT05128422
Capital Medical UniversityN/A
CompletedNormobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)
NCT04681651
Capital Medical UniversityPhase 2
RecruitingIntra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT)
NCT04664946
Hui-Sheng ChenN/A
UnknownRegional Hypothermia in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke
NCT04554797
Capital Medical UniversityN/A
RecruitingCerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring
NCT04217421
dr. M.J.N.L. BendersPhase 3
CompletedOxygenation of the Cerebrum and Cooling During TAVI - Part I
NCT01759563
Hasselt UniversityPhase 3
CompletedThe Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial
NCT00647998
University of PennsylvaniaPhase 2